AGL
agilon health, inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Feb 25 Agilon Health reported a decline in financial performance for fiscal…
- Feb 28 ▲ Three major passive institutional investors, Wells Fargo, Schwab, an…
- Mar 2 to Mar 9 ▲ 2 days of insider buys: $301.1K by 3 insiders, avg $0.5550
- May 26 ▲ Barclays upgrades
- Jul 23 ▼ Citigroup downgrades
- Aug 11 ▲ Citigroup upgrades
- Sep 15 ▲ Bernstein upgrades
- Nov 4 ▲ agilon health reported Q3 2026 revenue of $1.52B (+6% YoY) and net i…
- Nov 4 ▲ Earnings: AGL Q3 2026 Earnings: EPS $1.97 (+263.4% vs est)
Signal stack
Where each data set points today.
- InsidersBULLISH
3 insiders bought $301.1K. No open-market sales.
- InstitutionsMIXED
Q2 2026: 17 added (2 new), 13 trimmed or exited. Largest new: Marshall Wace $50.2M, Wealth Enhancement Advisory Services $12.4M.
- AnalystsBULLISH
8 of 19 rate it Buy or better.
- Short sellersSTEADY
Short interest −5.8% to 846.7K shares. 4.7 days to cover, ≈5.0% of shares.
- TrendUPTREND
28% above its 50-day average.
- SocialQUIET
No Reddit mentions this week. Last mention Nov 1.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| BlackRock, Inc. | ADD | $122.9M |
| GOLDMAN SACHS GROUP INC | TRIM | $73.6M |
| MARSHALL WACE, LLP | NEW | $50.2M |
| D. E. Shaw & Co., Inc. | TRIM | $41.8M |
| JANE STREET GROUP, LLC | DOUBLED | $29.3M |
| Nuveen, LLC | DOUBLED | $24.6M |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | NEW | $12.4M |
| Connor, Clark & Lunn Investment Management Ltd. | DOUBLED | $4.6M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
19 analysts| Date | Firm | Rating |
|---|---|---|
| Nov 13, 2026 | Wells Fargo MAINTAIN | Overweight |
| Nov 11, 2026 | StoneX MAINTAIN | Buy |
| Nov 5, 2026 | Evercore ISI Group MAINTAIN | In-Line |
| Sep 15, 2026 | Bernstein UPGRADE | Outperform |
| Aug 24, 2026 | JP Morgan MAINTAIN | Underweight |
| Aug 11, 2026 | Wells Fargo MAINTAIN | Overweight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Gertsch Timothy Chief Accounting Officer Aug 16, 2026 | TAX W/H | $1.6K |
Zamore Denise Chief Legal Officer Aug 1, 2026 | TAX W/H | $3.4K |
Schwaneke Jeffrey A. Chief Financial Officer Jul 1, 2026 | TAX W/H | $258.2K |
Mansukani Sharad Director Jun 2, 2026 | AWARD | 2,133 sh |
Battaglia Silvana Director Jun 2, 2026 | AWARD | 2,133 sh |
MCKENZIE DIANA Director Jun 2, 2026 | AWARD | 2,133 sh |
McLoughlin Karen Director Jun 2, 2026 | AWARD | 2,133 sh |
WILLIAMS RONALD A Director Jun 2, 2026 | AWARD | 2,133 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Washington
Short side
FINRA· Oct 30, 2026SecBot reports
7 filings · 2 bullish · 0 bearish · 2 mixed · 3 neutral- MIXED INST-CLUSTERNov 16, 2026
Institutional activity in agilon health during Q2 2026 was mixed: 17 buyers accumulated $186.8M in new holdings (led by Jane Street Group, Wealth Enhancement Advisory, and Nuveen) while 13 sellers reduced positions by $105.3M (led by Dimensional Fund Advisors and Goldman Sachs). The cluster…
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL INST-CLUSTERNov 10, 2026
In Q3 2026, five institutional investors added to AGL positions (net +$3.8M) while three trimmed…
The cluster shows mixed conviction: Nuveen's large trim dominates the selling side, while Barclays and Squarepoint doubled small positions. With 13F data 45+ days stale and no insider corroboration…
- BULLISH 8-KNov 4, 2026
agilon health reported Q3 2026 revenue of $1.52B (+6% YoY) and net income of $35M vs a net loss of…
The substantial guidance raise for Adjusted EBITDA (nearly doubling the midpoint) signals sustained margin improvement and operational leverage. Monitor Q4 2026 results for continued MSER…
- NEUTRAL DEFA14AApr 27, 2026
Agilon health filed a supplement to its proxy statement clarifying the appointment of Tim O'Rourke…
The supplement is administrative and does not change voting. The annual meeting is on June 2, 2026; no immediate trading action required. Monitor for any activist developments given the proxy fight…
All AGL filing & press-release reports (7)
- INST-CLUSTER reportNov 16, 2026
- INST-CLUSTER reportNov 10, 2026
- 8-K reportNov 4, 2026
- DEFA14A reportApr 27, 2026
- 8-K reportApr 27, 2026
- INST-CLUSTER reportFeb 28, 2026
- 8-K reportFeb 25, 2026